Hang-Yu Li

Hepatic arterial infusion chemotherapy-based triplet conversion therapy for hepatocellular carcinoma with portal vein tumor thrombus: Evidence, patient selection, and surgical endpoints.

Portal vein tumor thrombus (PVTT) is a biologically aggressive and clinically heterogeneous form of hepatocellular carcinoma (HCC). Global guidelines generally classify macrovascular invasion as advanced disease and prioritize systemic therapy, whereas selected East Asian practice pathways incorporate hepatic arterial...